Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Estephania Feria Anzaldo"'
Autor:
Sophia El Hamichi, Estephania Feria Anzaldo, Aaron S. Gold, Sander R. Dubovy, Timothy G. Murray
Publikováno v:
J Vitreoretin Dis
Purpose: This work aims to report the challenging diagnosis, treatment, and follow-up of a patient with persistent fetal vasculature (PFV) and retinoblastoma (RB). Methods: A 22-month-old boy presented with unilateral RB stage VB in the right eye and
Autor:
Sophia El, Hamichi, Khushi, Saigal, Estephania Feria, Anzaldo, Aaron, Gold, Audina M, Berrocal, Timothy G, Murray
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 53:159-163
A 23-month-old girl born at 23 weeks' gestational age with a birth weight of 453 g and retinopathy of prematurity (ROP) stage 4A in 360° and plus disease in both eyes was treated in another institution with laser; her treatment was complicated with
Autor:
Audina M. Berrocal, Timothy G. Murray, Sophia El Hamichi, Estephania Feria Anzaldo, Azeema Latiff, Aaron S. Gold
Publikováno v:
Optometry and Vision Science. 98:1408-1412
This article reports two cases reported of combined treatment with topical dorzolamide and intravitreal bevacizumab injections, successfully treating small full-thickness macular hole without the need for traditional macular hole surgery.This study a
Autor:
Diana M. Laura, Noy Ashkenazy, Estephania Feria Anzaldo, Catherin I. Negron, Audina M. Berrocal
Publikováno v:
Ophthalmic surgery, lasersimaging retina. 53(6)
BACKGROUND AND OBJECTIVE: The most common clinical features of X-linked retinoschisis (XLRS) include macular schisis in a spoke wheel pattern and peripheral schisis, though other findings such as vitreous veils, vascular attenuation, and subretinal f
Autor:
Alejandra Gonzalez-Dibildox, Guillermo Salcedo-Villanueva, Virgilio Morales-Canton, Estephania Feria-Anzaldo, Hugo Quiroz-Mercado, Juan C. Romo-Aguas, Raul Velez-Montoya, Abraham Alejandro Medina-Andrade, Edel Moreno-Paramo, Gerardo Garcia-Aguirre, Andres Lisker-Cervantes
Publikováno v:
International Ophthalmology. 39:2023-2031
To determine the effect achieved from a single dose of anti-VEGF treatment switch, in patients with nAMD previously treated with bevacizumab, switched to either aflibercept or ranibizumab, and to compare the response between aflibercept and ranibizum